Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Lung
Study Name
S1900A (LUNG-MAP Sub-Study): A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
https://www.clinicaltrials.gov/ct2/show/NCT03845296?term=S1900A+%28LUNG-MAP+Sub-Study%29&rank=1
Contact for Questions
Nurse - Tracy 517-364-2835

Site view: at a glance